References
- Adler RH, Sayek I. (1976). Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg 22:8–15.
- Baxter J, Lima TA, Huneke R, et al. (2020). The efficacy of hydrogel foams in talc pleurodesis. J Cardiothorac Surg 15:1–8.
- Beck TN, Deneka AY, Chai L, et al. (2019). An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion. BMC Cancer 19:1–8.
- Bhatnagar R, Piotrowska HE, Laskawiec-Szkonter M, et al. (2020). Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial. J Am Med Assoc 323:60.
- De Campos JRM, Vargas FS, De Campos Werebe E, et al. (2001). Thoracoscopy talc poudrage: a 15-year experience. Chest 119:801–6.
- Genofre EH, Vargas FS, Acencio MM, et al. (2009). Talc pleurodesis: evidence of systemic Inflammatory response to small size talc particles. Respir Med 103:91–7.
- Kennedy L, Rusch VW, Strange C, et al. (1994). Pleurodesis using talc slurry. Chest 106:342–6.
- Laub GW, Huneke RB, Kresh JY, et al. (2017). A novel triblock copolymer hydrogel foam delivery system to improve talc pleurodesis efficacy. J Am College Surg 225:e8.
- Mierzejewski M, Korczynski P, Krenke R, Janssen JP. (2019). Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration. Respir Res 20:1–16.
- Neragi-Miandoab S. (2006). Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 54:1–9.
- Pereira GG, Dimer FA, Guterres SS, et al. (2013). Formulation and characterization of poloxamer 407: thermoreversible gel containing polymeric microparticles and hyaluronic acid. Quim Nova 36:1121–5.
- Rodriguez-Panadero F, Antony VB. (1997). Pleurodesis: state of the art. Euro Resp J 10:1648–54.
- Shaw PH, Agarwal R. (2013). Pleurodesis for malignant pleural effusions. Coch Datab Syst Rev 2004:CD002916.
- Tessari L, Cavezzi A, Frullini A. (2001). Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27:58–60.
- Vargas FS, Antonangelo L, Vaz MA, et al. (2003). Pleurodesis induced by intrapleural injection of silver nitrate or talc in rabbits: can it be used in humans? J Pneumologia 29:57–63.
- Walker-Renard PB, Vaughan LM, Sahn SA. (1994). Chemical pleurodesis for malignant pleural effusions. Ann Internal Med 120:56–64.
- Xie C, Teixeira LR, McGovern JP, Light RW. (1998). Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am J Respir Crit Care Med 157:1441–4.